Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Pharma firm face...

    Pharma firm face charges of cheating SBI of Rs 157 crore

    Written by Ruby Khatun Khatun Published On 2017-09-07T16:26:50+05:30  |  Updated On 18 Aug 2021 2:50 PM IST

    CHANDIGARH: A Judicial Magistrate court in Chandigarh has framed charges against the directors and managers of Surya Pharmaceuticals Limited of allegedly committing a fraud against State Bank of India (SBI) of Rs 157 crore.


    The charges of cheating, criminal conspiracy, and forgery have been framed against directors Rajiv Goyal, Alka Goyal and Suhel Goyal, chief financial officer Hari Om Bhatia, manager Mukta Seth, and director (operations) of Dubai-based Kobian Private Limited Pramod Aggarwal under the sections 120-B (criminal conspiracy), 420 (cheating), 467 (forgery of valuable security), 468 (forgery for purpose of cheating) and 471 (using as genuine a forged document or electronic record) of the IPC.


    The trial in the case will begin on December 11.


    TOI reports that the SBI's special commercial branch of Chandigarh had approached the CBI on May 22, 2014, alleging that the accused had duped the bank to the tune of Rs 157.96 crore. The accused, who also include "other private and public persons", have also been accused of "causing wrongful loss" to the public sector bank.


    According to the complaint received by CBI, the said company had availed a working capital of worth Rs 1,100 crore in which SBI's share was Rs 405 crore. However, at the time of availing financial facilities, the accused allegedly cheated the bank by falsifying purchases and sales of the same products without addition of any processing value, wrongly showing purchases of pharmaceutical products from concerns dealing in information technology, telecommunication, electric and electronic products, which were not related to the business of Surya Pharmaceuticals. The fraud was committed from 2010 to 2012


    FIR was registered after an investigative audit was carried out by SBI in October 2013 which revealed that the bank was cheated of Rs 157.96 crores. CBI had sought search warrants to recover documents and other evidence in the case.

    Alka GoyalCBI)Chandigarhchargescheatingcriminal conspiracyforgeryfraudfraud chargesHari Om BhatiaJudicial Magistrate courtKobian Private LimitedMukta SethPharma FirmPramod AggarwalRajiv GoyalSBIState Bank of IndiaSuhel GoyalSurya Pharmaceuticals Limited
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok